Salute e Benessere
Duality Bio Appoints Hua Mu as Global Chief Medical Officer
"Dr. Mu's appointment comes at a pivotal moment as DualityBio approaches a new milestone in the capital markets," "His unique blend of full-cycle development experience in multinational pharma and hands-on expertise in the globalization of China's innovative drugs will strengthen our global multicenter clinical trial strategy. By implementing scientifically rigorous clinical development plans, we will enhance pipeline value and build clinical development infrastructure and capability fully aligned with FDA, EMA, and NMPA requirements. We are confident that Dr. Mu will accelerate our clinical progress, fuel DualityBio's global expansion, and solidify our leadership in next-generation ADC innovation."
"I am honored to embark on this new journey with DualityBio. My decision to join stems from a deep alignment with the company's global vision. My mission is to build a team with international regulatory expertise, integrate clinical resources across the U.S., Europe , and
China , and accelerate NDA filings for core assets—all while driving DualityBio's global clinical-commercial flywheel. Together, we will transition from a biotech to a biopharma, delivering accessible breakthrough therapies to patients worldwide."
Photo - https://mma.prnewswire.com/media/2658812/1.jpg
Logo - https://mma.prnewswire.com/media/2566332/Duality_Biologics_logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/duality-bio-appoints-hua-mu-as-global-chief-medical-officer-302421773.html